Editorial: Improving Extracorporeal Life Support Outcomes in Children

Frontiers in Pediatrics

article

Hitesh S. Sandhu¹  James D. Fortenberry²  Graeme MacLaren³ 

[1] Division of Pediatric Critical Care, Department of Pediatrics, University of Tennessee Health Science Center, United States;Division of Critical Care, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Emory University, United States;National University Hospital;Department of Paediatrics, University of Melbourne

关键词: extracorporeal life support;    long term outcomes;    collaborative research;    ECPR = extracorporeal CPR;    multi-organ failure;    hybrid ECLS;    ECLS for Glenn and Fontan circulation;   

DOI  :  10.3389/fped.2019.00140

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Extracorporeal life support (ECLS, also known as extracorporeal membrane oxygenation or ECMO) emerged in the 1970s as a potentially useful life-support therapy for refractory cardiac or respiratory failure in neonatal and pediatric patients (1–3). Following a successful randomized controlled trial of ECLS in neonatal respiratory failure in the mid-1990s (4, 5), ECLS became a standard of care in neonatal and pediatric intensive care medicine. In order to continue refining the use of ECLS in pediatrics, there have to be sustained efforts on improving long-term outcomes after ECLS and reducing complications. This may be best achieved by a multipronged strategy at the institutional level coupled to collaborative multicenter research, use of innovative clinical strategies, and use of the Extracorporeal Life Support Organization (ELSO) Registry and other databases to guide decision making.

【 授权许可】

CC BY